Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

Robert S. Janssen, Roberto Mangoo‐Karim, Pablo E. Pérgola, Matthias Girndt, Hamid Namini, Sophia Rahman, Sean Bennett, William L. Heyward, Jacob T. Martin

Vaccine · 2013 · 82 citations · 20 references

Concepts

References

20